Dr. Srinivas Chollangi

Manager
Bristol-Myers Squibb, USA

Highest Degree
Ph.D. in Bioengineering from University of Oklahoma, USA

My URL
https://livedna.org/91.1359

Share this Profile

Biography

Dr. Srinivas Chollangi is currently working as Scientist II at Bristol-Myers Squibb, USA. He obtained his Ph.D. in Bioengineering from University of Oklahoma, USA. He also worked as Post Doctoral Researcher at University of Texas Southwestern Medical Center, Dallas TX, and Graduate Research Assistant at University of Oklahoma, Norman OK. Dr. Srinivas Chollangi received honors includes Journal of Biological Chemistry article chosen as Outstanding paper of the year and Cover paper article, Wei Cao Award for Innovation sponsored by The University of Oklahoma for Outstanding Research in Ophthalmology, Travel Award for Best Research Poster, Invited member of Golden Key International Honor Society. He is also serving on the reviewer board for the journals Neurobiology of Disease, Biotechnology, International Journal of Biological Chemistry, and American Journal of Drug Discovery & Development, and Technical editorial board for Biotechnology journal. He has published 5 research papers in journals as well as 23 presentations and 2 patents contributed as author/co-author.

Area of Interest:

Molecular Sciences
Biochemistry
Molecular Biology
Biophysics
Drug Delivery

Selected Publications

  1. Chollangi, S., N.E. Jaffe, H. Cai, A. Bell, K. Patel et al., 2014. Use of High Throughput (HT) automation technologies to accelerate purification process development of an early phase monoclonal antibody (mAb). Bioprocess Int., 12: 48-52.

  2. Thompson, J.W., A.A. Salahudeen, S. Chollangi, J.C. Ruiz and C.A. Brautigam et al., 2012. Structural and molecular characterization of iron-sensing hemerythrin-like domain within F-box and leucine-rich repeat protein 5 (FBXL5). J. Biol. Chem., 287: 7357-7365.
    CrossRef  |  Direct Link  |  

  3. Chollangi, S., T. Mather, K.K. Rodgers and J.D. Ash, 2012. A unique loop structure in oncostatin M determines binding affinity toward oncostatin m receptor and leukemia inhibitory factor receptor. J. Biol. Chem., 287: 32848-32859.
    CrossRef  |  

  4. Chollangi, S., J.W. Thompson, J.C. Ruiz, K.H. Gardner and R.K. Bruick, 2012. Hemerythrin-like domain within F-box and leucine-rich repeat protein 5 (FBXL5) communicates cellular iron and oxygen availability by distinct mechanisms. J. Biol. Chem., 287: 23710-23717.
    Direct Link  |  

  5. Ueki, Y., S. Chollangi, Y.Z. Le and J.D. Ash, 2010. gp130 Activation in muller cells is not essential for photoreceptor protection from light damage. Adv. Exp. Med. Biol., 664: 655-661.
    PubMed  |  Direct Link  |  

  6. Ueki, Y., Y.Z. Le, S. Chollangi, W. Muller and J.D. Ash, 2009. Preconditioning-induced protection of photoreceptors requires activation of the signal-transducing receptor gp130 in photoreceptors. Proc. Nat. Acad. Sci., 106: 21389-21394.
    PubMed  |  Direct Link  |  

  7. Chollangi, S., J. Wang, A. Martin, J. Quinn and J.D. Ash, 2009. Preconditioning-induced protection from oxidative injury is mediated by Leukemia Inhibitory Factor Receptor (LIFR) and its ligands in the retina. Neurobiol. Dis., 34: 535-544.
    CrossRef  |  PubMed  |  Direct Link  |  

  8. Ueki, Y., J. Wang, S. Chollangi and J.D. Ash, 2008. STAT3 activation in photoreceptors by leukemia inhibitory factor is associated with protection from light damage. J. Neurochem., 105: 784-796.
    CrossRef  |  PubMed  |  Direct Link  |  
Member since June, 2010